Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS.
Salomon-Zimri S, Pushett A, Russek-Blum N, Van Eijk RPA, Birman N, Abramovich B, Eitan E, Elgrart K, Beaulieu D, Ennist DL, Berry JD, Paganoni S, Shefner JM, Drory VE. Salomon-Zimri S, et al. Among authors: drory ve. Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):263-271. doi: 10.1080/21678421.2022.2119868. Epub 2022 Sep 15. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36106817 Clinical Trial.
"ALS reversals": demographics, disease characteristics, treatments, and co-morbidities.
Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, van den Berg LH, Crayle J, Bedlack R; Pooled Resource Open-Access ALS Clinical Trials Consortium. Harrison D, et al. Among authors: drory ve. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):495-499. doi: 10.1080/21678421.2018.1457059. Epub 2018 Apr 2. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29607695
A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression.
Goldstein O, Kedmi M, Gana-Weisz M, Nefussy B, Vainer B, Fainmesser Y, Drory VE, Orr-Urtreger A. Goldstein O, et al. Among authors: drory ve. Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):280-285. doi: 10.1080/21678421.2020.1747496. Epub 2020 Apr 7. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 32253937
Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial.
Raveh E, Ben-Shimon A, Anisimov V, Kreitman R, Ben-Ami E, Nechushtan E, Birman N, Drory VE. Raveh E, et al. Among authors: drory ve. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5-6):495-501. doi: 10.1080/21678421.2023.2196315. Epub 2023 Apr 7. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37026395 Clinical Trial.
110 results